K192471 is an FDA 510(k) clearance for the RHIN1 Stylus. Classified as Electrosurgical, Cutting & Coagulation & Accessories within the GEI classification (a category for electrosurgical cutting and coagulation devices), Class II - Special Controls.
Submitted by Aerin Medical, Inc. (Sunnyvale, US). The FDA issued a Cleared decision on December 20, 2019 after a review of 101 days - within the typical 510(k) review window.
This device falls under the Ear, Nose, Throat FDA review panel, regulated under 21 CFR 878.4400 - the FDA ear, nose and throat device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Ear, Nose, Throat review framework, consistent with the majority of Class II 510(k) submissions.
View all Aerin Medical, Inc. devices
NCT02914236
Completed
Interventional
Industry-sponsored
Treatment of Nasal Airway Obstruction Using the Aerin Medical Device
A Prospective, Multi-Center Non-Randomized Study to Evaluate Treatment of Nasal Airway Obstruction Using the Aerin Medical Device
| Condition studied |
Nasal Obstruction |
| Study design |
Single group |
| Eligibility |
All sexes
· 22 Years+
|
| Principal investigator |
Scott Wolf, MD |
| Sponsor |
Aerin Medical
(industry)
|
Started 2016-09-27
→
Primary completion 2017-07-21
→
Completed 2017-08-18
Primary outcome
Improvement in NOSE Score
Secondary outcome
NOSE Responder Rate
View full study on ClinicalTrials.gov